pirenzepine has been researched along with Adult Neuronal Ceroid Lipofuscinosis in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with juvenile neuronal ceroid lipofuscinosis (JNCL) often have severe psychiatric symptoms." | 2.70 | New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study. ( Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäckman, ML | 1 |
| Aberg, LE | 1 |
| Aronen, ET | 1 |
| Santavuori, PR | 1 |
1 trial available for pirenzepine and Adult Neuronal Ceroid Lipofuscinosis
| Article | Year |
|---|---|
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; | 2001 |